Avoiding kidney damage in ICU sedation with sevoflurane: use isoflurane instead

J. Robert Sneyd*

*Corresponding author for this work

Research output: Contribution to journalEditorial

3 Downloads (Pure)

Abstract

Intensive care unit (ICU) sedation with sevoflurane is associated with nephrogenic diabetes insipidus. Given that isoflurane is now licenced (in Europe) for ICU sedation and has Investigational New Drug status in the USA, evidence indicates that clinicians should stop using sevoflurane in this indication except in the context of clinical trials.

Original languageEnglish
Pages (from-to)7-10
Number of pages4
JournalBritish Journal of Anaesthesia
Volume129
Issue number1
DOIs
Publication statusPublished - Jul 2022

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Keywords

  • acute kidney injury
  • diabetes insipidus
  • isoflurane
  • nephrotoxicity
  • sedation
  • sevoflurane

Fingerprint

Dive into the research topics of 'Avoiding kidney damage in ICU sedation with sevoflurane: use isoflurane instead'. Together they form a unique fingerprint.

Cite this